Keyword: GSK

News

US and Canada Approve GSK Shingles Vaccine

24.10.2017 - The US Food and Drug Administration on Oct. 20 approved Shingrix, the long awaited recombinant, adjuvant new shingles vaccine manufactured by UK drugmaker Glaxo SmithKline (GSK)...

News

Novartis to Close US Generics Unit, Keep Roche Stake

18.10.2017 - As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...

News

More Lawsuits Target US Merck’s Shingles Vaccine

26.07.2017 - US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from...

News

GSK Signs AI Pact with Exscientia

10.07.2017 - UK drugmaker GlaxoSmithKline (GSK) is to collaborate with artificial intelligence (AI) company Exscientia. The partnership will see Exscientia combine its AI-enabled platform with...

News

Drug Patent Losses Worth Billions Seen in 2017

03.05.2017 - Major pharmaceutical producers threaten to lose $26.5 billion in annual sales this year, as 18 branded drugs are due to expire, analysts for investment bank Bernstein said in a...

Plant Construction & Process Technology

Bioelectronic Medicines: A New Type of Personalization

27.04.2017 - Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...

News

GSK and Regeneron Back UK Biobank Project

29.03.2017 - UK drugmaker GlaxoSmithKline (GSK) and US biotech Regeneron Pharmaceuticals are investing in a gene sequencing project that uses anonymous patient data held by the UK Biobank. The...

News

Pfizer Said Looking for Gene Therapy Site

13.03.2017 - After acquiring the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, last year in a drive to be a major player...